[1] Baj J, Korona-Glowniak I, Forma A, et al. Mechanisms of the epithelial-mesenchymal transition and tumor microenvironment in Helicobacter pylori-induced Gastric Cancer[J]. Cells, 2020, 9:1055. [2] Choi IJ, MC Kook, YI Kim, et al. Helicobacter pylori therapy for the prevention of metachronous gastric cancer[J]. N Engl J Med, 2018, 378:1085-1095. [3] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68:394-424. [4] Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota[J]. Gut, 2018, 67:226-236. [5] Bakhti SZ, Latifi-Navid S, Mohammadi S, et al. Relev-ance of Helicobacter pylori vacA 3′-end region polymor-phism to gastric cancer[J]. Helicobacter, 2016, 21:305-316. [6] Tu S, Bhagat G, Cui G, et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice[J]. Cancer Cell, 2008, 14:408-419. [7] Obst B, Wagner S, Sewing KF, et al. Helicobacter pylori causes DNA damage in gastric epithelial cells[J]. Carcinogenesis, 2000, 21:1111-1115. [8] Yahiro K, Akazawa Y, Nakano M, et al. Helicobacter pylori VacA induces apoptosis by accumulation of connexin 43 in autophagic vesicles via a Rac1/ERK-dependent pathway[J]. Cell Death Discov, 2015, 1:15035. doi: 10.1038/cddiscovery.2015.35. [9] Noto JM, Peek RM. The Helicobacter pylori cag pathogenicity island[J]. Methods Mol Biol, 2012, 921:41-50. [10] El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms[J]. Gastroenterology, 2003, 124:1193-1201. [11] Crabtree JE, Farmery SM, Lindley IJ, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines[J]. J Clin Pathol, 1994, 47:945-950. [12] Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis[J]. Gut, 1991, 32:1473-1477. [13] Chen X, Zhao Y. Block of proliferation 1 promotes cell migration and invasion in human colorectal cancer cells via the JNK pathway[J]. J Clin Lab Anal, 2020, e23283. doi: 10.1002/jcla.23283. [14] Donati G, Bertoni S, Brighenti E, et al. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells[J]. Oncogene, 2011, 30:3274-3288. [15] Gao C, Guo X, Xue A, et al. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer[J]. Acta Biochim Biophys Sin (Shanghai), 2020, 52:310-319. |